Herbs for Low-Risk Skin Cancers and Precancers
Author:
- 1 June 2019
- journal article
- research article
- Published by SAGE Publications in Alternative and Complementary Therapies
- Vol. 25 (3) , 163-166
Abstract
Low-risk skin cancers and precancers are common skin ailments that primarily affect fair skinned individuals in areas of skin with high sun exposure. Currently the primary treatments available for these types of lesions include surgery and cryotherapy, with the less common use of chemotherapeutic agents either topically or orally. These treatments tend to leave lasting scars and have a high rate of recurrence. Several products derived from plants including oleogel from Betula spp. (birch) and ingenol mebutate from Euphorbia peplus (garden spurge) have demonstrated effectiveness as treatments for actinic keratoses, with minimal side effects, scarring, and recurrence. Other herbs with preclinical evidence are discussed, including Hypericum perforatum (St. John's wort), Camellia sinensis (green tea), Curcuma longa (turmeric), and Vitis vinifera (grape seed). Sun damage is the primary cause of these types of skin lesions; various botanical interventions for photoprotection are reviewed.Keywords
This publication has 15 references indexed in Scilit:
- From actinic keratosis to squamous cell carcinoma: pathophysiology revisitedJournal of the European Academy of Dermatology and Venereology, 2017
- Oral and systemic photoprotectionPhotodermatology, Photoimmunology & Photomedicine, 2014
- Pathobiology of actinic keratosis: Ultraviolet-dependent keratinocyte proliferationJournal of the American Academy of Dermatology, 2013
- Triterpenes Promote Keratinocyte Differentiation In Vitro, Ex Vivo and In Vivo: A Role for the Transient Receptor Potential Canonical (subtype) 6Journal of Investigative Dermatology, 2010
- Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosisJournal of the American Academy of Dermatology, 2009
- PEP005 (ingenol mebutate) gel, a novel agent for the treatment of actinic keratosis: Results of a randomized, double‐blind, vehicle‐controlled, multicentre, phase IIa studyAustralasian Journal of Dermatology, 2009
- Physical, Chemical and Pharmacological Characterization of a New Oleogel-Forming Triterpene Extract from the Outer Bark of Birch (Betulae Cortex)Planta Medica, 2006
- Betulinic Acid and Its Derivatives: A Review on their Biological PropertiesCurrent Medicinal Chemistry, 2005
- Antitumor Activity of 3-Ingenyl AngelateCancer Research, 2004
- HOME TREATMENT OF SKIN CANCER AND SOLAR KERATOSESAustralasian Journal of Dermatology, 1988